✦ LIBER ✦

Renal Cell Carcinoma: A Model System for Novel Drug Development?

✍ Scribed by Ronald M. Bukowski

Book ID: 119935411
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 62 KB
Volume: 6
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2008.n.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel Immunotherapeutic Strategies in De

Novel Immunotherapeutic Strategies in Development for Renal Cell Carcinoma

✍ Inman, Brant A.; Harrison, Michael R.; George, Daniel J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 488 KB

Emerging molecular classification in ren

Emerging molecular classification in renal cell carcinoma: implications for drug development

✍ Kathryn E. Hacker; W. Kimryn Rathmell 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 176 KB

Novel therapeutics for metastatic renal

Novel therapeutics for metastatic renal cell carcinoma

✍ Thomas E. Hutson; Robert A. Figlin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

## Abstract The treatment of metastatic renal cell carcinoma (RCC) has changed dramatically during the past few years. Sunitinib malate, sorafenib tosylate, bevacizumab with interferon α, temsirolimus, and everolimus have improved clinical outcomes in randomized phase 3 trials by inhibiting the vas

A prognostic model for metastatic renal-

A prognostic model for metastatic renal-cell carcinoma

✍ Galsky, Matthew D 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 107 KB

A novel murine model of human renal cell

A novel murine model of human renal cell carcinoma spinal metastasis

✍ Lin Wang; Shayan Rahman; Chia-Ying Lin; Juan Valdivia; Khoi Than; Frank La Marca 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 582 KB

Renal Cell Carcinoma || C-MET as a Novel

Renal Cell Carcinoma || C-MET as a Novel Target for the Treatment of Renal Cell Carcinoma

✍ Figlin, Robert A.; Rathmell, W. Kimryn; Rini, Brian I. 📂 Article 📅 2012 🏛 Springer US ⚖ 398 KB